REXO2 and gastric cancer: Above all, we hereby provide a new mechanism that is utilized by MECP2 to promote GC proliferation by the cell signaling pathways of MECP2/miR-338/P-REX2 or BMI1, which may be a potential therapeutic strategy for the treatment of GC in future.